Transforming preventive care to reduce mortality in low-income populations
Can a radical transformation of preventive care reduce mortality by 20% in low SES populations? Preparatory work focusing on AUD/heavy alcohol use, HIV risk, and cardiovascular risk
This study is looking at how making healthcare more personal and accessible can help save lives by 20% for people with lower incomes, especially by focusing on issues like alcohol use, HIV risk, and heart health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10992842 on NIH RePORTER |
What this research studies
This research investigates how a significant change in preventive healthcare can lower mortality rates by 20% among low socioeconomic status (SES) populations. It focuses on addressing issues like alcohol use disorder, HIV risk, and cardiovascular health through personalized care strategies. The approach includes tailoring screening intensity and frequency to individual needs, improving navigation through healthcare systems, and compensating for costs associated with care. The study aims to prepare for a larger trial that will rigorously test these methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 35-64 from low SES backgrounds who are at increased risk of mortality due to preventable health conditions.
Not a fit: Patients outside the age range of 35-64 or those not experiencing significant health disparities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a substantial decrease in preventable deaths among vulnerable populations.
How similar studies have performed: Previous research has shown that targeted preventive care can significantly improve health outcomes, suggesting that this approach may also be effective.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Braithwaite, Ronald Scott — New York University School of Medicine
- Study coordinator: Braithwaite, Ronald Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.